Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Testosterone therapy increases bone density in older men with low testosterone levels.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Apple polyphenol, especially oligomeric procyanidins, can reduce fat absorption and lower blood fat levels.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Mouse hair follicle cells briefly grow during the early hair growth phase, showing that these cells are important for starting the hair cycle.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

No treatment fully prevents hair loss from chemotherapy yet.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

Excessive selenium from a supplement caused toxicity but patients recovered with care.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.